Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single Ascending Dose Study of DSP-0378 in Healthy Japanese Adult Males
jRCT2071220068Phase 1Completed
- Sponsor
- Sumitomo Pharma
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Dravet syndrome and Lennox-Gastaut syndrome (LGS) comparing DSP-0378 with Placebo (2 arms). Primary endpoints: Safety and tolerability of DSP-0378, Pharmacokinetics of DSP-0378 and 1 more. Started Nov 2022; status: completed.
02
Drugs
DSP-0378
03
Conditions
Dravet syndromeLennox-Gastaut syndrome (LGS)
Beyond the preview
Go deeper on jRCT2071220068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071220068.